Marlan D Walker sold $44k of TXMD
Chief Executive Officer at TherapeuticsMD, Inc.. 19,050 shares at an average of $2.29, traded Dec 6, 2023, filed Dec 7, 2023.
Score components
- +25RoleCEO
- +6Trade size$44k at market
- +5Share of holdings soldSold 23% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001209191-23-057725, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 5, 2023 | MOption exercise Common Stock | +70,000 | $0.00 | $0 | 81,615 | Dec 7, 2023 |
| Dec 6, 2023 | SOpen-market sale Common Stock | -14,500 | $2.31 | $33k | 67,115 | Dec 7, 2023 |
| Dec 7, 2023 | SOpen-market sale Common Stock | -4,550 | $2.24 | $10k | 62,565 | Dec 7, 2023 |
| Dec 5, 2023 | MOption exercise Restricted Stock Unitsderivative | -70,000 | $0.00 | $0 | 0 | Dec 7, 2023 |
Related signals
Other insiders at TherapeuticsMD, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | TXMDbuy TherapeuticsMD, Inc. | Tommy G Thompson director | $14k 8,400 shares | +57% | |
| 33Weak | TherapeuticsMD, Inc. | Marlan D Walker Chief Executive Officer | $489 490 shares | +1% | |
| 23Weak | TherapeuticsMD, Inc. | Tommy G Thompson director | $326 325 shares | +2% | |
| 33Weak | TherapeuticsMD, Inc. | Marlan D Walker Chief Executive Officer | $1,994 2,303 shares | +3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.